Rank
|
Page title
|
Views
|
Daily average
|
Assessment
|
Importance
|
1
|
Norovirus
|
271,673
|
9,055
|
B
|
Top
|
2
|
COVID-19 pandemic
|
256,110
|
8,537
|
GA
|
Top
|
3
|
COVID-19
|
177,581
|
5,919
|
B
|
Top
|
4
|
Bell's palsy
|
122,505
|
4,083
|
B
|
Top
|
5
|
Epstein–Barr virus
|
121,531
|
4,051
|
B
|
Top
|
6
|
HIV/AIDS
|
105,907
|
3,530
|
GA
|
Top
|
7
|
Rabies
|
99,402
|
3,313
|
B
|
Top
|
8
|
Smallpox
|
99,070
|
3,302
|
GA
|
Top
|
9
|
Dengue fever
|
98,167
|
3,272
|
FA
|
Top
|
10
|
Prion
|
96,056
|
3,201
|
GA
|
Top
|
11
|
List of epidemics and pandemics
|
88,943
|
2,964
|
List
|
High
|
12
|
Human papillomavirus infection
|
81,920
|
2,730
|
B
|
Top
|
13
|
Shingles
|
81,004
|
2,700
|
GA
|
Top
|
14
|
Spanish flu
|
77,333
|
2,577
|
GA
|
Top
|
15
|
Respiratory syncytial virus
|
75,615
|
2,520
|
B
|
High
|
16
|
HIV
|
70,903
|
2,363
|
GA
|
Top
|
17
|
Molluscum contagiosum
|
70,839
|
2,361
|
B
|
High
|
18
|
Virus
|
69,859
|
2,328
|
FA
|
Top
|
19
|
Measles
|
69,794
|
2,326
|
B
|
Top
|
20
|
Creutzfeldt–Jakob disease
|
69,437
|
2,314
|
B
|
Top
|
21
|
Rhinovirus
|
64,304
|
2,143
|
C
|
High
|
22
|
Canine parvovirus
|
63,884
|
2,129
|
B
|
Top
|
23
|
Polio
|
60,595
|
2,019
|
FA
|
Top
|
24
|
Herpes simplex virus
|
58,481
|
1,949
|
B
|
Top
|
25
|
Rotavirus
|
58,462
|
1,948
|
FA
|
Top
|
26
|
Chickenpox
|
56,795
|
1,893
|
B
|
Top
|
27
|
Coronavirus
|
54,458
|
1,815
|
C
|
High
|
28
|
Infectious mononucleosis
|
54,217
|
1,807
|
B
|
Top
|
29
|
Hodgkin lymphoma
|
53,664
|
1,788
|
B
|
Top
|
30
|
Herpes
|
50,915
|
1,697
|
GA
|
Top
|
31
|
Gastroenteritis
|
50,292
|
1,676
|
GA
|
Top
|
32
|
Hand, foot, and mouth disease
|
45,927
|
1,530
|
B
|
High
|
33
|
Human metapneumovirus
|
45,890
|
1,529
|
C
|
High
|
34
|
Influenza A virus
|
45,181
|
1,506
|
B
|
Top
|
35
|
Mumps
|
45,157
|
1,505
|
B
|
Top
|
36
|
Marburg virus disease
|
44,140
|
1,471
|
C
|
High
|
37
|
Cytomegalovirus
|
43,488
|
1,449
|
B
|
Top
|
38
|
Ebola
|
42,105
|
1,403
|
B
|
Top
|
39
|
Chronic wasting disease
|
41,049
|
1,368
|
C
|
Top
|
40
|
Rosalind Franklin
|
40,552
|
1,351
|
B
|
High
|
41
|
Influenza
|
39,689
|
1,322
|
FA
|
High
|
42
|
COVID-19 lockdown in India
|
38,581
|
1,286
|
B
|
Mid
|
43
|
SARS-CoV-2
|
37,412
|
1,247
|
B
|
Top
|
44
|
Vaccine
|
36,789
|
1,226
|
B
|
Top
|
45
|
Influenza A virus subtype H5N1
|
36,769
|
1,225
|
B
|
Top
|
46
|
Canine distemper
|
36,558
|
1,218
|
B
|
Top
|
47
|
HPV vaccine
|
34,840
|
1,161
|
B
|
High
|
48
|
History of HIV/AIDS
|
34,268
|
1,142
|
B
|
Top
|
49
|
Variant Creutzfeldt–Jakob disease
|
33,727
|
1,124
|
B
|
High
|
50
|
Yellow fever
|
33,043
|
1,101
|
B
|
Top
|
51
|
Hepatitis C
|
32,338
|
1,077
|
GA
|
Top
|
52
|
COVID-19 vaccine
|
31,984
|
1,066
|
B
|
Top
|
53
|
Influenza B virus
|
31,789
|
1,059
|
C
|
High
|
54
|
COVID-19 pandemic in the United States
|
31,125
|
1,037
|
B
|
Low
|
55
|
Marburg virus
|
30,761
|
1,025
|
C
|
High
|
56
|
Timeline of the COVID-19 pandemic
|
30,416
|
1,013
|
List
|
Top
|
57
|
COVID-19 pandemic on cruise ships
|
29,901
|
996
|
B
|
High
|
58
|
Avian influenza
|
29,507
|
983
|
B
|
High
|
59
|
Croup
|
29,040
|
968
|
GA
|
Top
|
60
|
Hepatitis B
|
28,862
|
962
|
GA
|
Top
|
61
|
Bacteriophage
|
28,374
|
945
|
B
|
Top
|
62
|
Rubella
|
28,040
|
934
|
B
|
Top
|
63
|
Sapovirus
|
27,888
|
929
|
C
|
High
|
64
|
Kaposi's sarcoma
|
27,799
|
926
|
C
|
Mid
|
65
|
Adenoviridae
|
27,375
|
912
|
B
|
High
|
66
|
Common cold
|
26,852
|
895
|
GA
|
Top
|
67
|
Varicella zoster virus
|
26,292
|
876
|
C
|
High
|
68
|
Pandemic
|
23,849
|
794
|
B
|
High
|
69
|
HeLa
|
22,661
|
755
|
C
|
Mid
|
70
|
COVID-19 pandemic in India
|
22,353
|
745
|
B
|
High
|
71
|
Genital wart
|
21,988
|
732
|
B
|
Top
|
72
|
List of COVID-19 vaccine authorizations
|
21,749
|
724
|
List
|
Mid
|
73
|
Messenger RNA
|
20,830
|
694
|
C
|
High
|
74
|
B virus
|
19,496
|
649
|
C
|
Mid
|
75
|
COVID-19 pandemic by country and territory
|
19,355
|
645
|
List
|
Top
|
76
|
SARS
|
18,985
|
632
|
C
|
Top
|
77
|
Cold sore
|
18,324
|
610
|
C
|
Top
|
78
|
Edward Jenner
|
18,231
|
607
|
B
|
High
|
79
|
2009 swine flu pandemic
|
18,196
|
606
|
GA
|
High
|
80
|
Foot-and-mouth disease
|
17,972
|
599
|
B
|
High
|
81
|
Cervical cancer
|
17,966
|
598
|
B
|
High
|
82
|
COVID-19 lockdowns
|
17,917
|
597
|
B
|
Low
|
83
|
Parvovirus B19
|
17,642
|
588
|
C
|
Mid
|
84
|
Feline leukemia virus
|
17,628
|
587
|
C
|
High
|
85
|
Epidemiology of HIV/AIDS
|
17,513
|
583
|
C
|
High
|
86
|
Influenza A virus subtype H1N1
|
17,114
|
570
|
C
|
Top
|
87
|
West Nile virus
|
17,013
|
567
|
B
|
High
|
88
|
Smallpox vaccine
|
17,005
|
566
|
B
|
Mid
|
89
|
Amantadine
|
16,968
|
565
|
C
|
High
|
90
|
Genital herpes
|
16,729
|
557
|
C
|
High
|
91
|
COVID-19 lab leak theory
|
16,428
|
547
|
C
|
Low
|
92
|
Retrovirus
|
16,063
|
535
|
C
|
Top
|
93
|
Remdesivir
|
15,598
|
519
|
C
|
High
|
94
|
Enterovirus
|
15,515
|
517
|
C
|
High
|
95
|
Interferon
|
15,423
|
514
|
B
|
Top
|
96
|
Orthohantavirus
|
15,159
|
505
|
B
|
Top
|
97
|
Origin of COVID-19
|
14,958
|
498
|
Start
|
Mid
|
98
|
Hepatitis A
|
14,925
|
497
|
B
|
Top
|
99
|
Coxsackievirus
|
14,787
|
492
|
C
|
High
|
100
|
Antiviral drug
|
14,349
|
478
|
C
|
Top
|
101
|
List of deaths due to COVID-19
|
14,165
|
472
|
List
|
High
|
102
|
Timeline of HIV/AIDS
|
14,091
|
469
|
List
|
Mid
|
103
|
Human parainfluenza viruses
|
14,034
|
467
|
C
|
Mid
|
104
|
Varicella vaccine
|
13,541
|
451
|
B
|
Top
|
105
|
HIV/AIDS in the United States
|
13,151
|
438
|
C
|
Low
|
106
|
Vaccination
|
13,070
|
435
|
B
|
Top
|
107
|
Zidovudine
|
13,055
|
435
|
B
|
High
|
108
|
Mpox
|
13,026
|
434
|
C
|
High
|
109
|
COVID-19 vaccination in India
|
12,889
|
429
|
C
|
Low
|
110
|
Moderna
|
12,651
|
421
|
C
|
Low
|
111
|
Chikungunya
|
12,595
|
419
|
B
|
High
|
112
|
Herpesviridae
|
12,440
|
414
|
C
|
Top
|
113
|
Roseola
|
12,367
|
412
|
C
|
High
|
114
|
Feline immunodeficiency virus
|
12,005
|
400
|
C
|
High
|
115
|
Dengue vaccine
|
11,980
|
399
|
C
|
Low
|
116
|
Zika virus
|
11,976
|
399
|
B
|
Top
|
117
|
2002–2004 SARS outbreak
|
11,817
|
393
|
B
|
Mid
|
118
|
COVID-19 pandemic deaths
|
11,563
|
385
|
C
|
Low
|
119
|
Hammer-headed bat
|
11,541
|
384
|
GA
|
Low
|
120
|
COVID-19 misinformation
|
11,525
|
384
|
C
|
Low
|
121
|
Poliovirus
|
11,266
|
375
|
GA
|
High
|
122
|
COVID-19 pandemic in the United Kingdom
|
10,793
|
359
|
C
|
Low
|
123
|
Rabies virus
|
10,482
|
349
|
C
|
Top
|
124
|
Gardasil
|
10,237
|
341
|
B
|
High
|
125
|
SARS-CoV-2 Omicron variant
|
10,212
|
340
|
C
|
High
|
126
|
DNA polymerase
|
10,170
|
339
|
C
|
Top
|
127
|
RNA interference
|
10,094
|
336
|
FA
|
High
|
128
|
Myxomatosis
|
10,065
|
335
|
GA
|
High
|
129
|
Index case
|
10,026
|
334
|
Start
|
Low
|
130
|
Dengue virus
|
9,936
|
331
|
B
|
Top
|
131
|
Compartmental models in epidemiology
|
9,807
|
326
|
C
|
Mid
|
132
|
Influenza vaccine
|
9,803
|
326
|
B
|
Top
|
133
|
COVID-19 pandemic in the Philippines
|
9,770
|
325
|
B
|
Low
|
134
|
Tobacco mosaic virus
|
9,745
|
324
|
C
|
High
|
135
|
2020–2024 H5N1 outbreak
|
9,653
|
321
|
C
|
Low
|
136
|
Pithovirus
|
9,531
|
317
|
C
|
High
|
137
|
Timeline of the COVID-19 pandemic in the United States (2020)
|
9,524
|
317
|
C
|
Low
|
138
|
SV40
|
9,521
|
317
|
C
|
Mid
|
139
|
Rinderpest
|
9,050
|
301
|
B
|
High
|
140
|
Western African Ebola virus epidemic
|
8,896
|
296
|
GA
|
Mid
|
141
|
Operation Warp Speed
|
8,868
|
295
|
C
|
High
|
142
|
Tick-borne encephalitis
|
8,728
|
290
|
Start
|
Low
|
143
|
Viral hemorrhagic fever
|
8,579
|
285
|
C
|
High
|
144
|
Reverse transcriptase
|
8,535
|
284
|
B
|
Top
|
145
|
Subtypes of HIV
|
8,482
|
282
|
C
|
High
|
146
|
Nipah virus
|
8,312
|
277
|
Start
|
Mid
|
147
|
Viroid
|
8,237
|
274
|
C
|
High
|
148
|
Japanese encephalitis
|
8,184
|
272
|
B
|
High
|
149
|
Virus classification
|
8,165
|
272
|
C
|
Top
|
150
|
Hong Kong flu
|
8,150
|
271
|
C
|
Low
|
151
|
SARS-CoV-1
|
8,068
|
268
|
C
|
High
|
152
|
RNA polymerase
|
8,045
|
268
|
B
|
High
|
153
|
Host (biology)
|
7,992
|
266
|
GA
|
High
|
154
|
Respiratory syncytial virus vaccine
|
7,923
|
264
|
B
|
Mid
|
155
|
Zaire ebolavirus
|
7,876
|
262
|
C
|
Top
|
156
|
Human herpesvirus 6
|
7,792
|
259
|
C
|
High
|
157
|
Feline infectious peritonitis
|
7,757
|
258
|
C
|
High
|
158
|
Walter Reed
|
7,559
|
251
|
C
|
Low
|
159
|
Bioterrorism
|
7,537
|
251
|
B
|
Low
|
160
|
Hershey–Chase experiment
|
7,521
|
250
|
C
|
Mid
|
161
|
Merkel-cell carcinoma
|
7,521
|
250
|
C
|
Mid
|
162
|
Powassan virus
|
7,482
|
249
|
C
|
Mid
|
163
|
Yellow fever vaccine
|
7,465
|
248
|
C
|
High
|
164
|
COVID-19 pandemic in Australia
|
7,360
|
245
|
B
|
Low
|
165
|
Disease X
|
7,333
|
244
|
GA
|
Low
|
166
|
Parvoviridae
|
7,320
|
244
|
B
|
Mid
|
167
|
Gain-of-function research
|
7,296
|
243
|
Start
|
High
|
168
|
Swine influenza
|
7,245
|
241
|
B
|
High
|
169
|
Hepatitis C virus
|
7,240
|
241
|
B
|
Top
|
170
|
Severe acute respiratory syndrome coronavirus 2
|
7,163
|
238
|
Redirect
|
NA
|
171
|
RNA virus
|
7,095
|
236
|
B
|
High
|
172
|
Vaccine hesitancy
|
7,093
|
236
|
B
|
High
|
173
|
Carcinogenesis
|
6,994
|
233
|
B
|
Mid
|
174
|
Hepatitis B virus
|
6,804
|
226
|
C
|
Top
|
175
|
Rabies in animals
|
6,728
|
224
|
C
|
High
|
176
|
Great Barrington Declaration
|
6,721
|
224
|
B
|
Low
|
177
|
Orthomyxoviridae
|
6,672
|
222
|
B
|
High
|
178
|
Impact of the COVID-19 pandemic on cinema
|
6,655
|
221
|
B
|
Low
|
179
|
Variants of SARS-CoV-2
|
6,641
|
221
|
C
|
Mid
|
180
|
Lysogenic cycle
|
6,634
|
221
|
C
|
High
|
181
|
Impact of the COVID-19 pandemic on education
|
6,629
|
220
|
C
|
Low
|
182
|
Wuhan Institute of Virology
|
6,618
|
220
|
C
|
Mid
|
183
|
Transduction (genetics)
|
6,606
|
220
|
C
|
High
|
184
|
Viral disease
|
6,598
|
219
|
List
|
Top
|
185
|
Hantavirus pulmonary syndrome
|
6,586
|
219
|
Start
|
High
|
186
|
Measles vaccine
|
6,527
|
217
|
C
|
Low
|
187
|
Virology
|
6,509
|
216
|
B
|
Top
|
188
|
Attenuated vaccine
|
6,349
|
211
|
C
|
High
|
189
|
Lyssavirus
|
6,329
|
210
|
C
|
Mid
|
190
|
Lentivirus
|
6,162
|
205
|
C
|
Mid
|
191
|
Human T-lymphotropic virus 1
|
6,085
|
202
|
C
|
High
|
192
|
Metagenomics
|
6,047
|
201
|
GA
|
High
|
193
|
Henipavirus
|
6,030
|
201
|
C
|
High
|
194
|
Lady Mary Wortley Montagu
|
6,024
|
200
|
B
|
Low
|
195
|
Adeno-associated virus
|
5,994
|
199
|
B
|
High
|
196
|
History of COVID-19 vaccine development
|
5,967
|
198
|
C
|
Low
|
197
|
Human polyomavirus 2
|
5,887
|
196
|
C
|
High
|
198
|
Feline calicivirus
|
5,867
|
195
|
C
|
Top
|
199
|
COVID-19 pandemic in mainland China
|
5,841
|
194
|
C
|
High
|
200
|
Malaysian movement control order
|
5,830
|
194
|
B
|
Low
|
201
|
List of films impacted by the COVID-19 pandemic
|
5,803
|
193
|
List
|
Mid
|
202
|
Influenza pandemic
|
5,776
|
192
|
B
|
Top
|
203
|
2022–2023 mpox outbreak
|
5,718
|
190
|
B
|
Mid
|
204
|
Oncovirus
|
5,715
|
190
|
C
|
Top
|
205
|
Cowpox
|
5,676
|
189
|
C
|
Mid
|
206
|
Rubella virus
|
5,672
|
189
|
C
|
High
|
207
|
MERS
|
5,652
|
188
|
B
|
High
|
208
|
H5N1 vaccine
|
5,643
|
188
|
C
|
Low
|
209
|
2001 United Kingdom foot-and-mouth outbreak
|
5,632
|
187
|
C
|
Mid
|
210
|
Human mortality from H5N1
|
5,616
|
187
|
C
|
High
|
211
|
Variolation
|
5,603
|
186
|
C
|
High
|
212
|
Polio eradication
|
5,549
|
184
|
B
|
Mid
|
213
|
Lambda phage
|
5,519
|
183
|
B
|
High
|
214
|
Viral envelope
|
5,508
|
183
|
Start
|
Top
|
215
|
Simian immunodeficiency virus
|
5,500
|
183
|
C
|
High
|
216
|
Lytic cycle
|
5,476
|
182
|
C
|
High
|
217
|
Subacute sclerosing panencephalitis
|
5,463
|
182
|
C
|
Mid
|
218
|
COVID-19 pandemic in Canada
|
5,463
|
182
|
B
|
Mid
|
219
|
Herpes simplex encephalitis
|
5,451
|
181
|
Start
|
Low
|
220
|
Flavivirus
|
5,420
|
180
|
B
|
High
|
221
|
BK virus
|
5,405
|
180
|
B
|
Low
|
222
|
Capsid
|
5,390
|
179
|
C
|
Top
|
223
|
DNA virus
|
5,365
|
178
|
C
|
Top
|
224
|
Baltimore classification
|
5,280
|
176
|
B
|
Top
|
225
|
COVID-19 pandemic in New Zealand
|
5,264
|
175
|
C
|
Low
|
226
|
Phage therapy
|
5,189
|
172
|
C
|
Top
|
227
|
Ebolavirus
|
5,168
|
172
|
C
|
Mid
|
228
|
Travel during the COVID-19 pandemic
|
5,082
|
169
|
C
|
Low
|
229
|
COVID-19 pandemic in Victoria
|
5,072
|
169
|
C
|
Low
|
230
|
Virulence
|
5,062
|
168
|
C
|
High
|
231
|
Poxviridae
|
5,045
|
168
|
C
|
High
|
232
|
Hepatitis E
|
5,025
|
167
|
GA
|
High
|
233
|
Rotavirus vaccine
|
5,021
|
167
|
C
|
High
|
234
|
History of smallpox
|
4,961
|
165
|
C
|
Mid
|
235
|
Kaposi's sarcoma-associated herpesvirus
|
4,956
|
165
|
C
|
High
|
236
|
Incertae sedis
|
4,944
|
164
|
C
|
Low
|
237
|
Papillomaviridae
|
4,911
|
163
|
B
|
Top
|
238
|
COVID-19 pandemic in Italy
|
4,814
|
160
|
C
|
Mid
|
239
|
COVID-19 pandemic in Germany
|
4,807
|
160
|
C
|
Low
|
240
|
Global spread of H5N1
|
4,789
|
159
|
B
|
High
|
241
|
Molnupiravir
|
4,706
|
156
|
C
|
Mid
|
242
|
COVID-19 pandemic in Singapore
|
4,702
|
156
|
B
|
High
|
243
|
Xenophobia and racism related to the COVID-19 pandemic
|
4,674
|
155
|
List
|
Low
|
244
|
Iridovirus
|
4,666
|
155
|
C
|
Low
|
245
|
COVID-19 pandemic in the Republic of Ireland
|
4,641
|
154
|
C
|
Low
|
246
|
Shope papilloma virus
|
4,618
|
153
|
C
|
Mid
|
247
|
Escherichia virus T4
|
4,607
|
153
|
Start
|
Mid
|
248
|
Crimean–Congo hemorrhagic fever
|
4,584
|
152
|
C
|
High
|
249
|
Phage display
|
4,536
|
151
|
C
|
Mid
|
250
|
Hepatitis D
|
4,484
|
149
|
C
|
Mid
|
251
|
Sense (molecular biology)
|
4,482
|
149
|
C
|
High
|
252
|
Ravn virus
|
4,469
|
148
|
Start
|
Low
|
253
|
Timeline of the COVID-19 pandemic in 2019
|
4,411
|
147
|
List
|
High
|
254
|
Adenovirus infection
|
4,388
|
146
|
Start
|
Mid
|
255
|
SARS-CoV-2 Delta variant
|
4,382
|
146
|
C
|
Mid
|
256
|
Viral hepatitis
|
4,380
|
146
|
C
|
High
|
257
|
COVID-19 vaccine misinformation and hesitancy
|
4,380
|
146
|
B
|
Top
|
258
|
Astrovirus
|
4,370
|
145
|
B
|
Low
|
259
|
Measles morbillivirus
|
4,355
|
145
|
C
|
Top
|
260
|
1889–1890 pandemic
|
4,336
|
144
|
C
|
Mid
|
261
|
Face masks during the COVID-19 pandemic
|
4,298
|
143
|
B
|
Low
|
262
|
1978 smallpox outbreak in the United Kingdom
|
4,288
|
142
|
B
|
Low
|
263
|
Picornavirus
|
4,271
|
142
|
B
|
Mid
|
264
|
Human coronavirus OC43
|
4,262
|
142
|
C
|
Mid
|
265
|
Watermelon mosaic virus
|
4,233
|
141
|
C
|
Low
|
266
|
GS-441524
|
4,211
|
140
|
Start
|
Low
|
267
|
Economic impact of the COVID-19 pandemic
|
4,185
|
139
|
B
|
Low
|
268
|
Pandemic H1N1/09 virus
|
4,180
|
139
|
C
|
Mid
|
269
|
Inclusion bodies
|
4,161
|
138
|
C
|
High
|
270
|
COVID-19 pandemic in New South Wales
|
4,150
|
138
|
B
|
Low
|
271
|
Monkeypox virus
|
4,113
|
137
|
C
|
Mid
|
272
|
COVID-19 pandemic in Hubei
|
4,110
|
137
|
C
|
Mid
|
273
|
West Nile fever
|
4,100
|
136
|
C
|
High
|
274
|
Positive-strand RNA virus
|
4,046
|
134
|
C
|
High
|
275
|
Strain (biology)
|
4,028
|
134
|
C
|
High
|
276
|
Zika fever
|
4,016
|
133
|
B
|
High
|
277
|
Ebola virus cases in the United States
|
4,016
|
133
|
C
|
High
|
278
|
Non-cellular life
|
4,014
|
133
|
Start
|
Low
|
279
|
1957–1958 influenza pandemic
|
4,002
|
133
|
C
|
Mid
|
280
|
COVID-19 vaccination in the United States
|
3,996
|
133
|
Start
|
Low
|
281
|
Giant virus
|
3,994
|
133
|
C
|
High
|
282
|
Koplik's spots
|
3,987
|
132
|
C
|
Mid
|
283
|
COVID-19 pandemic in Maharashtra
|
3,973
|
132
|
C
|
Low
|
284
|
Borealpox virus
|
3,967
|
132
|
Start
|
Low
|
285
|
African swine fever virus
|
3,923
|
130
|
C
|
High
|
286
|
Human alphaherpesvirus 1
|
3,859
|
128
|
Start
|
Mid
|
287
|
Lassa fever
|
3,846
|
128
|
C
|
High
|
288
|
Peter Daszak
|
3,831
|
127
|
Start
|
Low
|
289
|
Endogenous retrovirus
|
3,825
|
127
|
C
|
Mid
|
290
|
Vaccinia
|
3,813
|
127
|
C
|
High
|
291
|
COVID-19 pandemic in North Korea
|
3,808
|
126
|
B
|
Mid
|
292
|
Paramyxoviridae
|
3,803
|
126
|
C
|
High
|
293
|
HBsAg
|
3,774
|
125
|
Start
|
High
|
294
|
Orthopoxvirus
|
3,747
|
124
|
C
|
High
|
295
|
Rhabdoviridae
|
3,734
|
124
|
C
|
High
|
296
|
COVID-19 pandemic in Europe
|
3,729
|
124
|
C
|
Low
|
297
|
Political impact of the COVID-19 pandemic
|
3,726
|
124
|
B
|
Low
|
298
|
Feline coronavirus
|
3,673
|
122
|
C
|
Mid
|
299
|
Metapneumovirus
|
3,669
|
122
|
Stub
|
Mid
|
300
|
Echovirus
|
3,660
|
122
|
List
|
Mid
|
301
|
Viral replication
|
3,651
|
121
|
C
|
Top
|
302
|
Negative-strand RNA virus
|
3,616
|
120
|
B
|
Mid
|
303
|
Marek's disease
|
3,612
|
120
|
C
|
Mid
|
304
|
HIV vaccine development
|
3,610
|
120
|
C
|
Mid
|
305
|
COVID-19 lockdown in China
|
3,594
|
119
|
C
|
High
|
306
|
Coronavirus spike protein
|
3,581
|
119
|
Start
|
Low
|
307
|
Arbovirus
|
3,529
|
117
|
C
|
Top
|
308
|
Mumps virus
|
3,520
|
117
|
B
|
High
|
309
|
MERS-related coronavirus
|
3,511
|
117
|
B
|
High
|
310
|
Australian bat lyssavirus
|
3,491
|
116
|
C
|
Low
|
311
|
Pigeon pox
|
3,480
|
116
|
Stub
|
Low
|
312
|
Epstein–Barr virus–associated lymphoproliferative diseases
|
3,478
|
115
|
C
|
Mid
|
313
|
Rolling circle replication
|
3,466
|
115
|
C
|
Mid
|
314
|
1977 Russian flu
|
3,404
|
113
|
C
|
Mid
|
315
|
Ross River virus
|
3,386
|
112
|
C
|
Mid
|
316
|
Spike protein
|
3,373
|
112
|
Start
|
Low
|
317
|
Ebola vaccine
|
3,342
|
111
|
C
|
Mid
|
318
|
2020–21 Singapore circuit breaker measures
|
3,329
|
110
|
C
|
Low
|
319
|
1793 Philadelphia yellow fever epidemic
|
3,327
|
110
|
C
|
Low
|
320
|
Filoviridae
|
3,311
|
110
|
Start
|
High
|
321
|
History of virology
|
3,306
|
110
|
B
|
Top
|
322
|
COVID-19 pandemic in South Africa
|
3,302
|
110
|
B
|
Mid
|
323
|
Bluetongue disease
|
3,287
|
109
|
B
|
High
|
324
|
Diagnosis of HIV/AIDS
|
3,269
|
108
|
B
|
High
|
325
|
Viral vector vaccine
|
3,259
|
108
|
Start
|
Low
|
326
|
Human alphaherpesvirus 2
|
3,243
|
108
|
Start
|
Mid
|
327
|
COVID-19 pandemic in Japan
|
3,236
|
107
|
C
|
Low
|
328
|
Jonathan Van-Tam
|
3,229
|
107
|
C
|
Low
|
329
|
Obelisk (biology)
|
3,220
|
107
|
Unknown
|
High
|
330
|
Solid lipid nanoparticle
|
3,179
|
105
|
C
|
Low
|
331
|
COVID-19 pandemic in New York City
|
3,149
|
104
|
Start
|
Low
|
332
|
Bat virome
|
3,146
|
104
|
GA
|
High
|
333
|
COVID-19 pandemic in Tamil Nadu
|
3,145
|
104
|
C
|
Low
|
334
|
Structure and genome of HIV
|
3,128
|
104
|
B
|
High
|
335
|
Human betaherpesvirus 5
|
3,117
|
103
|
C
|
High
|
336
|
Cacao swollen shoot virus
|
3,112
|
103
|
C
|
High
|
337
|
List of unproven methods against COVID-19
|
3,096
|
103
|
List
|
Mid
|
338
|
RNA-dependent RNA polymerase
|
3,076
|
102
|
C
|
Top
|
339
|
Natural reservoir
|
3,064
|
102
|
C
|
High
|
340
|
U.S. state and local government responses to the COVID-19 pandemic
|
3,042
|
101
|
C
|
Mid
|
341
|
Symptoms of COVID-19
|
3,027
|
100
|
C
|
Low
|
342
|
List of Ebola outbreaks
|
3,019
|
100
|
List
|
Low
|
343
|
Viral encephalitis
|
2,999
|
99
|
B
|
High
|
344
|
Superinfection
|
2,982
|
99
|
Stub
|
Mid
|
345
|
HIV trial in Libya
|
2,977
|
99
|
B
|
Low
|
346
|
List of biosafety level 4 organisms
|
2,975
|
99
|
List
|
Low
|
347
|
Pleomorphism (microbiology)
|
2,971
|
99
|
C
|
High
|
348
|
Viral shedding
|
2,958
|
98
|
Start
|
High
|
349
|
Congenital rubella syndrome
|
2,954
|
98
|
Start
|
Mid
|
350
|
Invertebrate iridescent virus 31
|
2,930
|
97
|
Start
|
Low
|
351
|
Impact of the COVID-19 pandemic on commercial air transport
|
2,921
|
97
|
C
|
Low
|
352
|
COVID-19 pandemic in Malaysia
|
2,906
|
96
|
B
|
High
|
353
|
Conjugate vaccine
|
2,899
|
96
|
C
|
High
|
354
|
Antibody-dependent enhancement
|
2,874
|
95
|
C
|
High
|
355
|
DNA vaccine
|
2,867
|
95
|
Start
|
Low
|
356
|
Tulip breaking virus
|
2,840
|
94
|
C
|
High
|
357
|
Pod People (Invasion of the Body Snatchers)
|
2,827
|
94
|
Start
|
Low
|
358
|
Ebola virus
|
2,819
|
93
|
Redirect
|
NA
|
359
|
Intracellular parasite
|
2,816
|
93
|
Start
|
Mid
|
360
|
Timeline of the COVID-19 pandemic in Canada
|
2,812
|
93
|
B
|
Mid
|
361
|
Enhanced community quarantine in Luzon
|
2,792
|
93
|
B
|
Low
|
362
|
Lamivudine
|
2,773
|
92
|
C
|
Mid
|
363
|
Riboviria
|
2,771
|
92
|
B
|
Top
|
364
|
Molluscum contagiosum virus
|
2,768
|
92
|
C
|
Mid
|
365
|
Virulent Newcastle disease
|
2,745
|
91
|
C
|
High
|
366
|
Hendra virus
|
2,738
|
91
|
Start
|
Mid
|
367
|
Plant virus
|
2,721
|
90
|
C
|
Top
|
368
|
Influenza A virus subtype H3N2
|
2,714
|
90
|
C
|
High
|
369
|
Reston virus
|
2,713
|
90
|
C
|
Low
|
370
|
Impact of the COVID-19 pandemic on the video game industry
|
2,708
|
90
|
C
|
Low
|
371
|
White House Coronavirus Task Force
|
2,706
|
90
|
C
|
Low
|
372
|
COVID-19 pandemic in South Korea
|
2,701
|
90
|
B
|
Low
|
373
|
Caliciviridae
|
2,685
|
89
|
C
|
Mid
|
374
|
Flat wart
|
2,671
|
89
|
Stub
|
Mid
|
375
|
Impact of the COVID-19 pandemic on the environment
|
2,670
|
89
|
C
|
Low
|
376
|
COVID-19 pandemic on Diamond Princess
|
2,667
|
88
|
Start
|
Low
|
377
|
List of diseases of the honey bee
|
2,663
|
88
|
List
|
High
|
378
|
Reverse-transcriptase inhibitor
|
2,656
|
88
|
C
|
High
|
379
|
Vaccine shedding
|
2,650
|
88
|
Start
|
Mid
|
380
|
Heterophile antibody test
|
2,646
|
88
|
C
|
Low
|
381
|
COVID-19 pandemic in Hong Kong
|
2,631
|
87
|
C
|
Low
|
382
|
Rift Valley fever
|
2,630
|
87
|
C
|
High
|
383
|
Polyomaviridae
|
2,619
|
87
|
C
|
High
|
384
|
Edible vaccine
|
2,613
|
87
|
C
|
Low
|
385
|
Negri body
|
2,602
|
86
|
Start
|
Mid
|
386
|
Eastern equine encephalitis
|
2,589
|
86
|
C
|
Mid
|
387
|
Coxsackie B virus
|
2,588
|
86
|
C
|
Mid
|
388
|
Timeline of the COVID-19 pandemic in New Zealand (2020)
|
2,581
|
86
|
List
|
Low
|
389
|
Viral evolution
|
2,577
|
85
|
C
|
High
|
390
|
COVID-19 pandemic in Sweden
|
2,558
|
85
|
B
|
Low
|
391
|
Primate T-lymphotropic virus
|
2,548
|
84
|
C
|
High
|
392
|
Timeline of the COVID-19 pandemic in January 2020
|
2,548
|
84
|
List
|
High
|
393
|
Alphavirus
|
2,544
|
84
|
B
|
Mid
|
394
|
COVID-19 testing
|
2,530
|
84
|
B
|
Low
|
395
|
Transmission and infection of H5N1
|
2,523
|
84
|
Unknown
|
Unknown
|
396
|
Virus latency
|
2,517
|
83
|
C
|
High
|
397
|
Rabbit hemorrhagic disease
|
2,514
|
83
|
B
|
Mid
|
398
|
Human coronavirus HKU1
|
2,512
|
83
|
C
|
High
|
399
|
Impact of the COVID-19 pandemic on sports
|
2,512
|
83
|
C
|
Mid
|
400
|
Viral pneumonia
|
2,507
|
83
|
Start
|
High
|
401
|
Koilocyte
|
2,504
|
83
|
Start
|
Low
|
402
|
Timeline of human vaccines
|
2,502
|
83
|
List
|
Low
|
403
|
Flaviviridae
|
2,501
|
83
|
Start
|
High
|
404
|
Emerging infectious disease
|
2,493
|
83
|
Start
|
Low
|
405
|
Vertically transmitted infection
|
2,484
|
82
|
C
|
High
|
406
|
PEGylation
|
2,483
|
82
|
C
|
Low
|
407
|
Virgin cleansing myth
|
2,472
|
82
|
Start
|
Low
|
408
|
Discrimination against people with HIV/AIDS
|
2,447
|
81
|
C
|
High
|
409
|
Phi X 174
|
2,442
|
81
|
Start
|
Mid
|
410
|
Timeline of the COVID-19 pandemic in March 2020
|
2,440
|
81
|
List
|
High
|
411
|
Timeline of the COVID-19 pandemic in New Zealand (2021)
|
2,440
|
81
|
List
|
Low
|
412
|
Baculoviridae
|
2,420
|
80
|
C
|
Mid
|
413
|
Human coronavirus 229E
|
2,409
|
80
|
Start
|
Mid
|
414
|
SARS-CoV-2 Alpha variant
|
2,402
|
80
|
C
|
Low
|
415
|
Innate resistance to HIV
|
2,389
|
79
|
C
|
High
|
416
|
FFP standards
|
2,379
|
79
|
C
|
Mid
|
417
|
Lassa mammarenavirus
|
2,377
|
79
|
Start
|
Mid
|
418
|
Human betaherpesvirus 7
|
2,374
|
79
|
C
|
Mid
|
419
|
Carnivore protoparvovirus 1
|
2,364
|
78
|
Start
|
Mid
|
420
|
COVID-19 pandemic in California
|
2,360
|
78
|
C
|
Mid
|
421
|
COVID-19 pandemic in Kerala
|
2,360
|
78
|
C
|
Low
|
422
|
SARS-related coronavirus
|
2,357
|
78
|
C
|
High
|
423
|
Ivermectin during the COVID-19 pandemic
|
2,350
|
78
|
B
|
Low
|
424
|
Nipah virus infection
|
2,343
|
78
|
C
|
High
|
425
|
Mimivirus
|
2,328
|
77
|
C
|
Mid
|
426
|
Oncolytic virus
|
2,327
|
77
|
B
|
Mid
|
427
|
Spillover infection
|
2,320
|
77
|
Start
|
Mid
|
428
|
HIV/AIDS in Russia
|
2,307
|
76
|
Start
|
Low
|
429
|
Double-stranded RNA viruses
|
2,292
|
76
|
Start
|
High
|
430
|
COVID-19 vaccination mandates in the United States
|
2,288
|
76
|
Start
|
Low
|
431
|
Banana bunchy top virus
|
2,275
|
75
|
C
|
Mid
|
432
|
2020 coronavirus pandemic in Germany
|
2,272
|
75
|
Redirect
|
NA
|
433
|
Cytopathic effect
|
2,268
|
75
|
C
|
High
|
434
|
List of virus species
|
2,256
|
75
|
List
|
Top
|
435
|
Human coronavirus NL63
|
2,256
|
75
|
C
|
Low
|
436
|
Kyasanur Forest disease
|
2,240
|
74
|
B
|
Mid
|
437
|
Feline spongiform encephalopathy
|
2,221
|
74
|
Start
|
Low
|
438
|
Oropouche orthobunyavirus
|
2,205
|
73
|
Start
|
Mid
|
439
|
HA-tag
|
2,197
|
73
|
Start
|
High
|
440
|
HIV/AIDS in Thailand
|
2,192
|
73
|
Start
|
Low
|
441
|
Arenavirus
|
2,188
|
72
|
C
|
High
|
442
|
Deployment of COVID-19 vaccines
|
2,177
|
72
|
C
|
High
|
443
|
Flu season
|
2,170
|
72
|
C
|
High
|
444
|
COVID-19 pandemic in North America
|
2,164
|
72
|
C
|
Mid
|
445
|
Hantavirus hemorrhagic fever with renal syndrome
|
2,148
|
71
|
Start
|
High
|
446
|
Orthornavirae
|
2,145
|
71
|
B
|
High
|
447
|
COVID-19 vaccination in the United Kingdom
|
2,132
|
71
|
C
|
Low
|
448
|
M13 bacteriophage
|
2,128
|
70
|
Start
|
Mid
|
449
|
Black flying fox
|
2,128
|
70
|
C
|
Mid
|
450
|
COVID-19 pandemic in France
|
2,109
|
70
|
B
|
Mid
|
451
|
Timeline of the COVID-19 pandemic in the United Kingdom (January–June 2020)
|
2,077
|
69
|
List
|
Low
|
452
|
Orf (disease)
|
2,074
|
69
|
Start
|
Low
|
453
|
Sedoreoviridae
|
2,069
|
68
|
C
|
Mid
|
454
|
Psittacine beak and feather disease
|
2,067
|
68
|
Start
|
Mid
|
455
|
Chinese government response to COVID-19
|
2,066
|
68
|
B
|
Mid
|
456
|
Cervarix
|
2,062
|
68
|
C
|
Mid
|
457
|
Viral load
|
2,057
|
68
|
Start
|
Mid
|
458
|
COVID-19 pandemic in Gujarat
|
2,042
|
68
|
Start
|
Low
|
459
|
Lumpy skin disease
|
2,030
|
67
|
C
|
Mid
|
460
|
Face masks during the COVID-19 pandemic in the United States
|
2,023
|
67
|
C
|
Low
|
461
|
COVID-19 pandemic in Pakistan
|
2,011
|
67
|
B
|
Low
|
462
|
COVID-19 pandemic in New York (state)
|
2,008
|
66
|
C
|
Low
|
463
|
History of the COVID-19 pandemic in the United Kingdom
|
1,986
|
66
|
C
|
High
|
464
|
Anthony Epstein
|
1,983
|
66
|
Start
|
Mid
|
465
|
Bunyavirales
|
1,973
|
65
|
C
|
Mid
|
466
|
Eczema herpeticum
|
1,964
|
65
|
Start
|
Low
|
467
|
Social impact of the COVID-19 pandemic
|
1,962
|
65
|
C
|
Low
|
468
|
Kivu Ebola epidemic
|
1,954
|
65
|
GA
|
High
|
469
|
1976 Zaire Ebola virus outbreak
|
1,951
|
65
|
C
|
Low
|
470
|
Pandoravirus
|
1,926
|
64
|
Start
|
High
|
471
|
Equid alphaherpesvirus 1
|
1,907
|
63
|
C
|
Mid
|
472
|
Feed a cold, starve a fever
|
1,902
|
63
|
C
|
Low
|
473
|
Superspreading event
|
1,895
|
63
|
C
|
High
|
474
|
Hemagglutination assay
|
1,888
|
62
|
C
|
Mid
|
475
|
Jeremy Farrar
|
1,885
|
62
|
C
|
Low
|
476
|
HBeAg
|
1,883
|
62
|
Start
|
Low
|
477
|
COVID-19 pandemic in Russia
|
1,883
|
62
|
C
|
Low
|
478
|
Timeline of the COVID-19 pandemic in England (2022)
|
1,879
|
62
|
List
|
Low
|
479
|
Tick-borne encephalitis virus
|
1,856
|
61
|
C
|
High
|
480
|
T7 RNA polymerase
|
1,854
|
61
|
Start
|
Low
|
481
|
Priya Abraham
|
1,839
|
61
|
Start
|
Low
|
482
|
Neurotropic virus
|
1,815
|
60
|
Start
|
High
|
483
|
Original antigenic sin
|
1,812
|
60
|
C
|
Mid
|
484
|
Human bocavirus
|
1,808
|
60
|
C
|
Mid
|
485
|
Hepadnaviridae
|
1,807
|
60
|
C
|
Mid
|
486
|
Coronaviridae
|
1,789
|
59
|
Start
|
High
|
487
|
Hemagglutinin (influenza)
|
1,779
|
59
|
C
|
High
|
488
|
Marburgvirus
|
1,776
|
59
|
C
|
High
|
489
|
Timothy A. Springer
|
1,774
|
59
|
C
|
Low
|
490
|
HIV superinfection
|
1,769
|
58
|
C
|
Mid
|
491
|
COVID-19 community quarantines in the Philippines
|
1,769
|
58
|
Start
|
Low
|
492
|
Variably protease-sensitive prionopathy
|
1,760
|
58
|
Start
|
Low
|
493
|
Lentiviral vector in gene therapy
|
1,753
|
58
|
C
|
Low
|
494
|
Antigenic shift
|
1,751
|
58
|
Start
|
High
|
495
|
HIV/AIDS in the Philippines
|
1,747
|
58
|
Start
|
Low
|
496
|
Coxsackie A virus
|
1,738
|
57
|
Start
|
Mid
|
497
|
Multiplicity of infection
|
1,731
|
57
|
Start
|
Mid
|
498
|
2015–16 Zika virus epidemic
|
1,721
|
57
|
B
|
Mid
|
499
|
MOG antibody disease
|
1,719
|
57
|
C
|
Mid
|
500
|
Fowlpox
|
1,718
|
57
|
Start
|
Low
|